Want to track DRUG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bright Minds Biosciences Inc. (DRUG) Statistics
Valuation metrics
Market Cap 712.6M
Enterprise value 686.51M
Trailing P/E (ttm) -35.04
Forward P/E -
PEG ratio 0.47
Price/Sales (ttm) -
Price/Book (mrq) 3.24
Enterprise Value/Revenue -
Enterprise Value/EBITDA -17.27
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 107.33K
Average volume (90 days) 352.08K
Price summary
52-Week low 38
52-Week high 123.75
Beta -
50-Day moving average 74.42
200-Day moving average 79.86
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 14 Jul 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.08%
Return on equity -0.13%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.51
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 31.35
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 121.97%
Book value per share (mrq) 31.35
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
